H.R. 1613 · 118th Congress

Drug Price Transparency in Medicaid Act of 2023

Introduced on Mar 17, 2023 by Earl L. "Buddy" Carter (R-GA-1). 37 cosponsors, 14 of them from another party. Latest action (Mar 24, 2023): Referred to the Subcommittee on Health.

Stage
Introduced
Introduced
Mar 17, 2023
Cosponsors
37
14 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program.

Subjects

  • Business records
  • Congressional oversight
  • Government information and archives
  • Health care costs and insurance
  • Home and outpatient care
  • Inflation and prices
  • Medicaid
  • Prescription drugs
  • Public contracts and procurement
  • Retail and wholesale trades
  • State and local government operations
  • User charges and fees

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Earl L. "Buddy" CarterR-GA-1Sponsor

Democrats · 14

Republicans · 23

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Mar 17, 2023Introduced in House
  2. Mar 17, 2023Introduced in House
  3. Mar 17, 2023 · HouseReferred to the House Committee on Energy and Commerce.
  4. Mar 24, 2023 · HouseReferred to the Subcommittee on Health.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. The MetroHealth System12 reports
    $1.6M reported (all issues)
  2. Indiana University Health, Inc.10 reports
    $600K reported (all issues)Federal contractor: INDIANA UNIVERSITY HEALTH, INC.$1.4M in contracts, FY2026AI match · 100%
  3. THE KROGER CO.10 reports
    $4.2M reported (all issues)
  4. The Cigna Group and subsidiaries (FKA Cigna Corporation7 reports
    $140K reported (all issues)
  5. TEVA PHARMACEUTICALS USA, INC.6 reports
    $2.5M reported (all issues)Federal contractor: TEVA PHARMACEUTICALS USA, INC.$25.9M in contracts, FY2026AI match · 100%
  6. 340B HEALTH5 reports
    $1.6M reported (all issues)
  7. AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)5 reports
    $14.2M reported (all issues)
  8. CVS HEALTH5 reports
    $11M reported (all issues)
  9. FOOD MARKETPLACE INC.5 reports
    $1.7M reported (all issues)
  10. GSK (fka GLAXOSMITHKLINE INC.)5 reports
    $6.3M reported (all issues)
  11. HIGHMARK INC.5 reports
    $830K reported (all issues)
  12. INDEPENDENT PHARMACY COOPERATIVE5 reports
    $270K reported (all issues)Federal contractor: INDEPENDENT PHARMACY COOPERATIVEAI match · 99%
  13. MERCK & CO., INC.5 reports
    $11.1M reported (all issues)Federal contractor: MERCK SHARP & DOHME LLC$445.3K in contracts, FY2026AI match · 100%
  14. NATIONAL ASSOCIATION OF CHAIN DRUG STORES, INC.5 reports
    $4.2M reported (all issues)
  15. NATIONAL COMMUNITY PHARMACISTS ASSOCIATION5 reports
    $1.8M reported (all issues)Federal contractor: NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONAI match · 100%
  16. NATIONWIDE CHILDREN'S HOSPITAL, INC.5 reports
    $275K reported (all issues)
  17. National Taxpayers Union5 reports
    $150K reported (all issues)
  18. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA5 reports
    $37.4M reported (all issues)
  19. The Cigna Group and subsidiaries (Formerly Cigna Corporation5 reports
    $10.2M reported (all issues)
  20. The Leukemia & Lymphoma Society4 reports
    $1M reported (all issues)
  21. American Society of Health-System Pharmacists2 reports
    $430K reported (all issues)Federal contractor: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS INC$350.5K in contracts, FY2026AI match · 100%
  22. Blue Cross and Blue Shield of Florida, Inc.2 reports
    $360K reported (all issues)
  23. Cigna Corporation2 reports
    $180K reported (all issues)Federal contractor: CIGNA WORLDWIDE INSURANCE BRANCH$2.5M in contracts, FY2026AI match · 99%
  24. GUIDEWELL MUTUAL HOLDING CORPORATION2 reports
  25. PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION2 reports
    $10.1M reported (all issues)
  26. AMERICAN PHARMACIES, INC.1 report
    $60K reported (all issues)
  27. HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY1 report
    $10K reported (all issues)
  28. NOVARTIS CORPORATION1 report
    $960K reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  29. OCHSNER CLINIC FOUNDATION1 report
    $200K reported (all issues)
  30. TAKEDA PHARMACEUTICALS AMERICA, INC.1 report
    $510K reported (all issues)Federal contractor: TAKEDA PHARMACEUTICALS AMERICA, INC.$1.6M in contracts, FY2026AI match · 100%

Reports filed in 2023, 2024, 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.